Diabetic cardiomyopathy (DCM) is a major chronic complication of diabetes mellitus. Multiple signaling pathways may combine to produce pathological changes in DCM. Curcumin is a potent pleiotropic molecule that regulates multiple pathways. Pharmacokinetics of curcumin makes limited usage in clinical settings. Various approaches to improve curcumin pharmacokinetics are addressed.